Johnson & Johnson (JNJ) Asset Utilization Ratio (2009 - 2026)
Johnson & Johnson's (JNJ) quarterly Asset Utilization Ratio came in at 0.49 in Q2 2026, up 4.05% year-over-year from 0.47 in Q2 2025, and up 1.16% quarter-over-quarter from 0.48 in Q1 2026.
Analysis
Johnson & Johnson (JNJ) Asset Utilization Ratio (2009 - 2026) Analysis & Trends
Johnson & Johnson has disclosed Asset Utilization Ratio across 18 years of filings, most recently posting 0.49 for Q2 2026.
- In Q2 2026, Asset Utilization Ratio rose 4.05% year-over-year to 0.49; the TTM figure through Jun 2026 stood at 0.49 (up 4.05% YoY), while the FY2025 annual figure was 0.5, down 2.8% from the prior year.
- Asset Utilization Ratio came in at 0.49 for Q2 2026 at Johnson & Johnson, up from 0.48 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.51 in Q4 2023 to a low of 0.42 in Q2 2023.
- Average Asset Utilization Ratio over 5 years is 0.48, with a median of 0.48 recorded in 2025.
- Year-over-year, Asset Utilization Ratio slipped 14.21% in 2023 and advanced 19.32% in 2024.
- Over 5 years, Asset Utilization Ratio stood at 0.47 in 2022, then rose by 8.01% to 0.51 in 2023, then dropped by 2.91% to 0.5 in 2024, then fell by 3.05% to 0.48 in 2025, then climbed by 1.4% to 0.49 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.49 in Q2 2026, 0.48 in Q1 2026, and 0.48 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 0.57 |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 0.31 |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 0.56 |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 0.36 |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 0.69 |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | 0.77 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 0.49 |
| Mar 29, 2026 | 0.48 |
| Dec 28, 2025 | 0.48 |
| Sep 28, 2025 | 0.48 |
| Jun 29, 2025 | 0.47 |
| Mar 30, 2025 | 0.48 |
| Dec 29, 2024 | 0.50 |
| Sep 29, 2024 | 0.49 |
| Jun 30, 2024 | 0.49 |
| Mar 31, 2024 | 0.50 |
| Dec 31, 2023 | 0.51 |
| Oct 1, 2023 | 0.47 |
| Jul 2, 2023 | 0.42 |
| Apr 2, 2023 | 0.42 |
| Jan 1, 2023 | 0.44 |
| Oct 2, 2022 | 0.47 |
| Jul 3, 2022 | 0.49 |
| Apr 3, 2022 | 0.49 |
| Oct 3, 2021 | 0.51 |
| Jul 4, 2021 | 0.51 |